Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
BMJ Case Rep ; 12(9)2019 Sep 18.
Artigo em Inglês | MEDLINE | ID: mdl-31537587

RESUMO

We describe an 11-year prospective clinical and radiologic course of a 6-year-old boy with bilateral Legg-Calvé-Perthes disease, who was treated with intravenous pamidronate (IV-PAM). His baseline radiographs showed grade IV avascular necrosis/Catterall stage IV, and at worst he progressed to lateral pillar/Herring stage C bilaterally. His disease initially was extremely functionally limiting with expected poor outcome with eventual joint replacement. Because IV-PAM stops bone breakdown and allows for ongoing bone formation while revascularisation of bone occurs, we hypothesised that IV-PAM could act as an adjunct to traditional treatment to help heal the femoral heads. Our patient received nine once monthly doses of IV-PAM (1 mg/kg/dose) over 13 months, along with Petrie/broomstick casts and physiotherapy. Remarkably, over time, his femoral heads healed. Now, at 11-year follow-up, he has excellent functional and radiologic outcome with congruence between femoral head and acetabulum, no residual osteonecrosis and minimal loss of femoral head sphericity.


Assuntos
Conservadores da Densidade Óssea/administração & dosagem , Necrose da Cabeça do Fêmur/tratamento farmacológico , Doença de Legg-Calve-Perthes/tratamento farmacológico , Pamidronato/uso terapêutico , Conservadores da Densidade Óssea/uso terapêutico , Moldes Cirúrgicos , Criança , Cabeça do Fêmur/efeitos dos fármacos , Articulação do Quadril/diagnóstico por imagem , Articulação do Quadril/patologia , Humanos , Doença de Legg-Calve-Perthes/reabilitação , Doença de Legg-Calve-Perthes/cirurgia , Masculino , Pamidronato/administração & dosagem , Tenotomia/métodos , Resultado do Tratamento
3.
Can Respir J ; 21(1): 17-9, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24288697

RESUMO

Severe combined immunodeficiency (SCID) is considered to be a pediatric emergency, with respiratory distress being the most common presenting symptom. The authors present two cases of SCID in children <4 months of age with respiratory distress at a tertiary care centre due to a recently described homozygous CD3 delta mutation found only in the Mexican Mennonite population. Failure to respond to broad-spectrum antibiotics prompted investigation for possible SCID. Bronchial alveolar lavage fluid from both patients grew Pneumocystis jiroveci, and flow cytometry revealed absent T cells. The CD3 delta gene is believed to be important in T cell differentiation and maturation. The present article reminds pediatricians and pediatric respirologists that the key to diagnosing SCID is to have a high index of suspicion if there is poor response to conventional therapies.


Assuntos
Complexo CD3/genética , Infecções Respiratórias/diagnóstico por imagem , Imunodeficiência Combinada Severa/diagnóstico , Canadá , Humanos , Lactente , Masculino , México/etnologia , Radiografia , Infecções Respiratórias/imunologia , Imunodeficiência Combinada Severa/genética , Imunodeficiência Combinada Severa/imunologia , Centros de Atenção Terciária
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...